| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |